Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


17.06.2019

1 Ann Surg
1 Ann Surg Oncol
7 Anticancer Res
3 BMC Cancer
1 Cancer Lett
5 Dis Colon Rectum
1 Eur J Surg Oncol
17 Gastrointest Endosc
3 Int J Colorectal Dis
1 Int J Oncol
1 J Clin Oncol
1 J Natl Cancer Inst
1 Lancet Gastroenterol Hepatol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg

  1. RASKOV H, Soby JH, Troelsen J, Bojesen RD, et al
    Driver Gene Mutations and Epigenetics in Colorectal Cancer.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003393.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. TANAKA T, Yamashita K
    ASO Author Reflections: ASCL2, a Marker of Dynamic Colon Stem Cell, Involved in Wnt Pathway Activation Reflects Anti-cancer Drug Resistance in Primary Colorectal Cancer.
    Ann Surg Oncol. 2019 Jun 13. pii: 10.1245/s10434-019-07469.
    PubMed     Text format    


    Anticancer Res

  3. MOKKARALA M, Noda C, Malone C, Ramaswamy R, et al
    Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases.
    Anticancer Res. 2019;39:3071-3077.
    PubMed     Text format     Abstract available

  4. GZIL A, Szylberg L, Jaworski D, Dominiak J, et al
    The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Anticancer Res. 2019;39:2689-2697.
    PubMed     Text format     Abstract available

  5. WU MH, Hung YW, Gong CL, Chao CC, et al
    Contribution of Caspase-8 Genotypes to Colorectal Cancer Risk in Taiwan.
    Anticancer Res. 2019;39:2791-2797.
    PubMed     Text format     Abstract available

  6. ISHIKAWA D, Takasu C, Kashihara H, Nishi M, et al
    The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer.
    Anticancer Res. 2019;39:2855-2860.
    PubMed     Text format     Abstract available

  7. RYU S, Suwa K, Kitagawa T, Aizawa M, et al
    Real-Time Fluorescence Vessel Navigation Using Indocyanine Green During Laparoscopic Colorectal Cancer Surgery.
    Anticancer Res. 2019;39:3009-3013.
    PubMed     Text format     Abstract available

  8. VIRGILIO E, Balducci G, Mercantini P, Ferri M, et al
    Curative and Prophylactic Surgery of Young-onset Colorectal Cancer in Inherited Syndromes: A 15-Year Monocentric Retrospective Experience.
    Anticancer Res. 2019;39:3131-3136.
    PubMed     Text format     Abstract available

  9. ETO S, Kawahara H, Matsumoto T, Hirabayashi T, et al
    Preoperative Neutrophil-Lymphocyte Ratio Is a Predictor of Bowel Obstruction Due to Colorectal Cancer Growth.
    Anticancer Res. 2019;39:3185-3189.
    PubMed     Text format     Abstract available


    BMC Cancer

  10. TANABE T, Shida D, Tsukamoto S, Morizono G, et al
    Metachronous metastasis to inguinal lymph nodes from sigmoid colon adenocarcinoma with abdominal wall metastasis: a case report.
    BMC Cancer. 2019;19:180.
    PubMed     Text format     Abstract available

  11. FENG Y, Qian W, Zhang Y, Peng W, et al
    CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    BMC Cancer. 2019;19:576.
    PubMed     Text format     Abstract available

  12. CALLEBOUT E, Ribeiro SM, Laurent S, De Man M, et al
    Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report.
    BMC Cancer. 2019;19:567.
    PubMed     Text format     Abstract available


    Cancer Lett

  13. CHENG X, Feng H, Wu H, Jin Z, et al
    Corrigendum to "Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer" [Cancer Lett. 431 (2018) 105-114].
    Cancer Lett. 2019 Jun 4. pii: S0304-3835(19)30315.
    PubMed     Text format    


    Dis Colon Rectum

  14. VU JV, Matusko N, Hendren S, Regenbogen SE, et al
    Patient-Reported Unmet Needs in Colorectal Cancer Survivors After Treatment for Curative Intent.
    Dis Colon Rectum. 2019;62:815-822.
    PubMed     Text format     Abstract available

  15. LEE KH, Kim JS, Kim JY
    Necessity of Genetic Evaluation of Metachronous Metastases of Colorectal Cancer: Quantitative Analysis of Genetic Discordance Between Metachronous Metastases and Radically Resected Primary Colorectal Cancers Using Next-Generation Sequencing.
    Dis Colon Rectum. 2019;62:832-839.
    PubMed     Text format     Abstract available

  16. FORD MM, Camp JV, Geiger TM, Hopkins MB, et al
    Assessing Hereditary Colorectal Cancer Referral Patterns to a Tertiary Care Center: A Novel Approach Using Geographic Information System Mapping.
    Dis Colon Rectum. 2019;62:840-848.
    PubMed     Text format     Abstract available

  17. SHARIQ OA, Hanson KT, McKenna NP, Kelley SR, et al
    Does Metabolic Syndrome Increase the Risk of Postoperative Complications in Patients Undergoing Colorectal Cancer Surgery?
    Dis Colon Rectum. 2019;62:849-858.
    PubMed     Text format     Abstract available

  18. WANIS KN, Maleyeff L, Van Koughnett JAM, H D Colquhoun P, et al
    Health and Economic Impact of Intensive Surveillance for Distant Recurrence After Curative Treatment of Colon Cancer: A Mathematical Modeling Study.
    Dis Colon Rectum. 2019;62:872-881.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  19. GKEKAS I, Novotny J, Fabian P, Nemecek R, et al
    Deficient mismatch repair as a prognostic marker in stage II colon cancer patients.
    Eur J Surg Oncol. 2019 May 28. pii: S0748-7983(19)30461.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  20. FUKUNAGA S, Nagami Y, Shiba M, Sakai T, et al
    Impact of preoperative biopsy sampling on severe submucosal fibrosis on endoscopic submucosal dissection for colorectal laterally spreading tumors: a propensity score analysis.
    Gastrointest Endosc. 2019;89:470-478.
    PubMed     Text format     Abstract available

  21. GIBSON DJ, Mooney T, Mooney J, Mulcahy HE, et al
    Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gastrointest Endosc. 2019;89:518-522.
    PubMed     Text format     Abstract available

  22. GESSL I, Waldmann E, Penz D, Majcher B, et al
    Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy.
    Gastrointest Endosc. 2019;89:496-502.
    PubMed     Text format     Abstract available

  23. WALTER B, Klare P, Strehle K, Aschenbeck J, et al
    Improving the quality and acceptance of colonoscopy preparation by reinforced patient education with short message service: results from a randomized, multicenter study (PERICLES-II).
    Gastrointest Endosc. 2019;89:506-513.
    PubMed     Text format     Abstract available

  24. QUENEHERVE L, David G, Bourreille A, Hardouin JB, et al
    Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases.
    Gastrointest Endosc. 2019;89:626-636.
    PubMed     Text format     Abstract available

  25. REX DK, Dekker E
    How we resect colorectal polyps <20 mm in size.
    Gastrointest Endosc. 2019;89:449-452.
    PubMed     Text format    

  26. DESAI M, Bilal M, Hamade N, Gorrepati VS, et al
    Increasing adenoma detection rates in the right side of the colon comparing retroflexion with a second forward view: a systematic review.
    Gastrointest Endosc. 2019;89:453-459.
    PubMed     Text format     Abstract available

  27. JUNG Y, Joo YE, Kim HG, Jeon SR, et al
    Relationship between the endoscopic withdrawal time and adenoma/polyp detection rate in individual colonic segments: a KASID multicenter study.
    Gastrointest Endosc. 2019;89:523-530.
    PubMed     Text format     Abstract available

  28. RONDONOTTI E, Paggi S, Amato A, Mogavero G, et al
    Blue-light imaging compared with high-definition white light for real-time histology prediction of colorectal polyps less than 1 centimeter: a prospective randomized study.
    Gastrointest Endosc. 2019;89:554-564.
    PubMed     Text format     Abstract available

  29. BHUTANI MS
    Cytomegalovirus-associated colonic pseudotumor.
    Gastrointest Endosc. 2019;89:641-642.
    PubMed     Text format    

  30. DESOMER L, Tate DJ, Bahin FF, Awadie H, et al
    A systematic description of the post-EMR defect to identify risk factors for clinically significant post-EMR bleeding in the colon.
    Gastrointest Endosc. 2019;89:614-624.
    PubMed     Text format     Abstract available

  31. WONG JCT, Chiu HM, Kim HS, Byeon JS, et al
    Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Gastrointest Endosc. 2019;89:607-613.
    PubMed     Text format     Abstract available

  32. TAKEUCHI Y, Sawaya M, Oka S, Tamai N, et al
    Efficacy of autofluorescence imaging for flat neoplasm detection: a multicenter randomized controlled trial (A-FLAT trial).
    Gastrointest Endosc. 2019;89:460-469.
    PubMed     Text format     Abstract available

  33. NGAMRUENGPHONG S, Kamal A, Akshintala V, Hajiyeva G, et al
    Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
    Gastrointest Endosc. 2019;89:602-606.
    PubMed     Text format     Abstract available

  34. ANDERSON JC, Kahi CJ, Sullivan A, MacPhail M, et al
    Comparing adenoma and polyp miss rates for total underwater colonoscopy versus standard CO2: a randomized controlled trial using a tandem colonoscopy approach.
    Gastrointest Endosc. 2019;89:591-598.
    PubMed     Text format     Abstract available

  35. KLARE P, Sander C, Prinzen M, Haller B, et al
    Automated polyp detection in the colorectum: a prospective study (with videos).
    Gastrointest Endosc. 2019;89:576-582.
    PubMed     Text format     Abstract available

  36. SHIRIN H, Shpak B, Epshtein J, Karstensen JG, et al
    G-EYE colonoscopy is superior to standard colonoscopy for increasing adenoma detection rate: an international randomized controlled trial (with videos).
    Gastrointest Endosc. 2019;89:545-553.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  37. INAMOTO S, Kawada K, Okamura R, Hida K, et al
    Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
    Int J Colorectal Dis. 2019;34:1303-1315.
    PubMed     Text format     Abstract available

  38. HARVEY PR, Rees J, Baldwin S, Waheed H, et al
    Outcomes of colorectal stents when used as a bridge to curative resection in obstruction secondary to colorectal cancer.
    Int J Colorectal Dis. 2019;34:1295-1302.
    PubMed     Text format     Abstract available

  39. SHEN F, Hong X
    Prognostic value of N1c in colorectal cancer: a large population-based study using propensity score matching.
    Int J Colorectal Dis. 2019 Jun 15. pii: 10.1007/s00384-019-03328.
    PubMed     Text format     Abstract available


    Int J Oncol

  40. OLEJNICZAK-KEDER A, Szarynska M, Wronska A, Siedlecka-Kroplewska K, et al
    Effects of 5-FU and anti-EGFR antibody in combination with ASA on the spherical culture system of HCT116 and HT29 colorectal cancer cell lines.
    Int J Oncol. 2019 May 23. doi: 10.3892/ijo.2019.4809.
    PubMed     Text format     Abstract available


    J Clin Oncol

  41. UENO H, Ishiguro M, Nakatani E, Ishikawa T, et al
    Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    J Clin Oncol. 2019 Jun 10:JCO1802059. doi: 10.1200/JCO.18.02059.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  42. SOMSOUK M, Rachocki C, Mannalithara A, Garcia D, et al
    Effectiveness and cost of organized outreach for colorectal cancer screening: A Randomized Controlled Trial.
    J Natl Cancer Inst. 2019 Jun 12. pii: 5513785. doi: 10.1093.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  43. SCHREUDERS EH, Grobbee EJ, Nieuwenburg SAV, Kapidzic A, et al
    Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Lancet Gastroenterol Hepatol. 2019 Jun 10. pii: S2468-1253(19)30176.
    PubMed     Text format     Abstract available


    PLoS One

  44. LIN XH, Jiang JK, Luo JC, Lin CC, et al
    The long term microbiota and metabolic status in patients with colorectal cancer after curative colon surgery.
    PLoS One. 2019;14:e0218436.
    PubMed     Text format     Abstract available

  45. CHAN JCY, Diakos CI, Engel A, Chan DLH, et al
    Tumor sidedness is not an independent prognostic marker of colorectal cancer patients undergoing curative resection: A retrospective cohort study.
    PLoS One. 2019;14:e0218207.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  46. GOTO N, Fukuda A, Yamaga Y, Yoshikawa T, et al
    Lineage tracing and targeting of IL17RB(+) tuft cell-like human colorectal cancer stem cells.
    Proc Natl Acad Sci U S A. 2019 Jun 10. pii: 1900251116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: